Ignite Creation Date:
2025-12-24 @ 9:56 PM
Ignite Modification Date:
2026-02-20 @ 7:24 PM
Study NCT ID:
NCT02647632
Status:
COMPLETED
Last Update Posted:
2017-06-29
First Post:
2015-12-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Assess Efficacy and Safety of Grazoprevir/Elbasvir Associated With Sofosbuvir and Ribavirin in HCV Genotype 1 or 4-infected Patients Who Failed Direct Acting Antivirals (DAA) Bitherapy With Sofosbuvir
Sponsor:
ANRS, Emerging Infectious Diseases
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-01
Start Date Type:
None
Primary Completion Date:
2017-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-04
Completion Date Type:
ACTUAL
First Submit Date:
2015-12-16
First Submit QC Date:
None
Study First Post Date:
2016-01-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-28
Last Update Post Date:
2017-06-29
Last Update Post Date Type:
ACTUAL